Neurocrine Biosciences | NBIX - Assets

Neurocrine Biosciences reported $2.37B in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Acadia Pharmaceuticals ACAD:US USD 587.81M 14.68M
Acorda Therapeutics ACOR:US USD 395.6M 2.26M
Agios Pharmaceuticals AGIO:US USD 1.24B 58.4M
ALKERMES ALKS:US USD 1.96B 22.08M
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Amgen AMGN:US USD 65.12B 1.42B
Aptinyx Inc APTX:US USD 76.2M 16.1M
Biogen BIIB:US USD 24.55B 300.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Cytokinetics CYTK:US USD 1.01B 61.19M
Dynavax Technologies DVAX:US USD 985.85M 13.49M
Enanta Pharmaceuticals ENTA:US USD 347.53M 27.88M
Exelixis EXEL:US USD 3.07B 110.12M
Gilead Sciences GILD:US USD 63.17B 614M
Halozyme Therapeutics HALO:US USD 1.84B 23.03M
Intercept Pharmaceuticals ICPT:US USD 553.71M 5.69M
Intra Cellular Therapies ITCI:US USD 754.78M 27.22M
IONIS PHARMACEUT IONS:US USD 2.53B 111.9M
Nektar Therapeutics NKTR:US USD 710.6M 70.41M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Prothena PRTA:US USD 758.04M 203.6M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Repligen RGEN:US USD 2.52B 62.13M
Rigel Pharmaceuticals RIGL:US USD 134.28M 18.67M
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
Teva Pharmaceutical TEVA:IT USD 44.01B 246M
Ultragenyx Pharmaceutical RARE:US USD 1.55B 73.03M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B
YTE INCY:US USD 5.84B 330.77M